US4364401012 - Common Stock
HOLOGIC INC
NASDAQ:HOLX (12/20/2024, 8:16:58 PM)
After market: 71.65 0 (0%)71.65
+0.89 (+1.26%)
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products dedicated to serve the healthcare needs of women. The company is headquartered in Marlborough, Massachusetts. The company is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical and Skeletal Health. Diagnostics segment offers a range of diagnostic products, which are used to aid in the screening and diagnosis of human diseases. Breast Health segment offers a portfolio of solutions for breast cancer care in the areas of radiology, breast surgery, pathology and treatment. The company also offers wireless breast surgery localization and lymphatic tracing solutions. GYN Surgical segment products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Fluent fluid management system and Acessa ProVu laparoscopic radiofrequency ablation system. Skeletal Health segment products include Horizon DXA Systems and Fluoroscan Insight FD.
HOLOGIC INC
250 Campus Drive
Marlborough MASSACHUSETTS 01752
P: 15082632900
CEO: STEPHEN P. MACMILLAN
Employees: 6990
Website: https://www.hologic.com/
Hologic (HOLX) closed the most recent trading day at $70.76, moving -0.99% from the previous trading session.
In the closing of the recent trading day, Hologic (HOLX) stood at $73.64, denoting a -1.93% change from the preceding trading day.
Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Here you can normally see the latest stock twits on HOLX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: